Nihon Kohden : Notice regarding disclosure of information in line with TCFD recommendations
July 12, 2022 at 02:54 am EDT
Share
Nihon Kohden hereby announces that it has disclosed information on climate change in line with the recommendations of the Task Force on Climate-related Financial Disclosures (TCFD)*1.
As addressing climate change is one of the most critical social issues facing global society and one of the most significant management issues for us, Nihon Kohden expressed its support for TCFD in May 2022.
Nihon Kohden has analyzed climate-related risks and opportunities by management and members of the Sustainability Promotion Committee and disclosed information on the four pillars of Governance, Strategy, Risk Management, and Metrics and Targets. For details, please refer to the sustainability page*2 on our website.
Nihon Kohden continues to embrace sustainability across business and corporate activities under its three-year business plan, BEACON 2030 Phase I. We will strengthen our response to climate change and enhance information disclosure with the aim of contributing to the realization of a carbon-free society.
*1 TCFD (Task Force on Climate-related Financial Disclosures): A task force established by the Financial Stability Board (FSB) at the request of the G20 (Financial and World Economic Summit) to enhance the disclosure of climate-related financial information. TCFD website: https://www.fsb-tcfd.org/
Attachments
Original Link
Original Document
Permalink
Disclaimer
Nihon Kohden Corporation published this content on 12 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 July 2022 06:53:02 UTC.
NIHON KOHDEN CORPORATION is a Japan-based company engaged in the research, development, manufacture and sale of medical electronic equipment, as well as the provision of maintenance and repair services. The Company mainly operates medical electronics related business. The Company offers electroencephalograph, electromyographic, evoked potential testing equipment, electrocardiographs, cardiac catheterization equipment, diagnostic information systems and related consumables (paper, electrodes, catheters and others), biological information monitors, clinical information systems, artificial respiration, artificial ear, hemocytometer, ultrasonic diagnostic equipment, research equipment and transformers, among others. The Company is also engaged in the sales promotion for its products, as well as the general affair-related and manpower dispatching businesses.